Life|March 10, 2026

Briefing: GOP Senator Investigates FDA Over Rare Disease Drug Rejections

Strategic angle: Sen. Ron Johnson raises concerns about the FDA's handling of treatments for rare diseases after discussions with Commissioner Marty Makary.

Editorial Staff·1 min read

Summary

Sen. Ron Johnson is questioning the FDA's drug approval process.
Focus on treatments for rare diseases that have been rejected.
Discussion with FDA Commissioner Marty Makary highlights concerns.

Key Facts

Fact	Value
Senator	Ron Johnson
Agency	FDA
Date of Investigation	March 10, 2026

Sources

STAT: https://www.statnews.com/2026/03/10/ron-johnson-investigating-fda-rare-disease-drug-denials/?utm_campaign=rss